1. Home
  2. ROP vs HLN Comparison

ROP vs HLN Comparison

Compare ROP & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROP
  • HLN
  • Stock Information
  • Founded
  • ROP 1981
  • HLN 2022
  • Country
  • ROP United States
  • HLN United Kingdom
  • Employees
  • ROP N/A
  • HLN N/A
  • Industry
  • ROP Industrial Machinery/Components
  • HLN Package Goods/Cosmetics
  • Sector
  • ROP Industrials
  • HLN Consumer Discretionary
  • Exchange
  • ROP Nasdaq
  • HLN Nasdaq
  • Market Cap
  • ROP 58.3B
  • HLN 48.2B
  • IPO Year
  • ROP 1992
  • HLN N/A
  • Fundamental
  • Price
  • ROP $512.53
  • HLN $9.81
  • Analyst Decision
  • ROP Buy
  • HLN Buy
  • Analyst Count
  • ROP 12
  • HLN 1
  • Target Price
  • ROP $633.18
  • HLN $10.95
  • AVG Volume (30 Days)
  • ROP 797.2K
  • HLN 8.2M
  • Earning Date
  • ROP 10-22-2025
  • HLN 07-31-2025
  • Dividend Yield
  • ROP 0.64%
  • HLN 1.84%
  • EPS Growth
  • ROP 5.46
  • HLN 41.64
  • EPS
  • ROP 14.24
  • HLN 0.23
  • Revenue
  • ROP $7,468,100,000.00
  • HLN $15,096,588,575.00
  • Revenue This Year
  • ROP $13.79
  • HLN $1.38
  • Revenue Next Year
  • ROP $8.34
  • HLN $4.24
  • P/E Ratio
  • ROP $36.12
  • HLN $42.85
  • Revenue Growth
  • ROP 13.59
  • HLN N/A
  • 52 Week Low
  • ROP $499.47
  • HLN $8.86
  • 52 Week High
  • ROP $595.17
  • HLN $11.42
  • Technical
  • Relative Strength Index (RSI)
  • ROP 38.55
  • HLN 52.02
  • Support Level
  • ROP $509.13
  • HLN $9.77
  • Resistance Level
  • ROP $524.90
  • HLN $9.93
  • Average True Range (ATR)
  • ROP 7.45
  • HLN 0.13
  • MACD
  • ROP -0.41
  • HLN 0.01
  • Stochastic Oscillator
  • ROP 12.39
  • HLN 64.20

About ROP Roper Technologies Inc.

Roper Technologies is a holding company focused on acquiring, managing, and developing niche market-leading technology businesses. The company operates a decentralized business model whereby each portfolio company operates independently from the others. Roper positions itself as a free cash flow compounder, whereby excess free cash flow generated by its portfolio businesses is repatriated to the parent company, which is then utilized to acquire additional businesses. Presently, the company operates 30 distinct businesses with over three-fourths of the revenue coming from software products and over two-thirds of revenue coming from recurring and reoccurring sources.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: